Urogenital Neoplasms  >>  Provenge (sipuleucel-T)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Provenge (sipuleucel-T) / Bausch Health
NCT01832870: Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer

Completed
1
9
US
sipuleucel-T, Provenge, ipilimumab, Yervoy
Prostate Oncology Specialists, Inc.
Prostate Cancer, Castrate Resistant Prostate Cancer
02/16
02/16

Download Options